State Street Investment Management · 2006-06-19 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | +$46.0M | — | — | $480.9M | 每日估算 |
| 2026-07-30 | +$1.9M | — | — | $428.4M | 每日估算 |
| 2026-07-29 | -$2.9M | — | — | $428.4M | 每日估算 |
| 2026-07-28 | -$47.9M | — | — | $428.4M | 每日估算 |
| 2026-07-27 | +$3.8M | — | — | $476.0M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
State Street Navigator Securities Lending Portfolio II State Street Navigator Securities Lending Portfolio II | STIV | 24,400,789 | $24.4M | 7.93% |
Enliven Therapeutics Inc Enliven Therapeutics Inc | EC | 192,297 | $7.5M | 2.45% |
Corcept Therapeutics Inc Corcept Therapeutics Inc | EC | 174,971 | $7.1M | 2.29% |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、nasdaq_etf_summary、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-26 | +$3.8M | — | — | $476.0M | 每日估算 |
| 2026-03-31 | -$31,149 | $21.6M | $21.6M | $307.9M | SEC 月度 |
| 2026-02-28 | +$28.2M | $33.9M | $5.7M | — | SEC 月度 |
| 2026-01-31 | +$61.6M | $83.8M | $22.3M | — | SEC 月度 |
| EC |
| 126,197 |
| $6.7M |
| 2.16% |
Perrigo Co PLC Perrigo Co PLC | EC | 601,785 | $6.5M | 2.10% |
Axsome Therapeutics Inc Axsome Therapeutics Inc | EC | 37,013 | $6.3M | 2.03% |
Innoviva Inc Innoviva Inc | EC | 263,314 | $6.1M | 1.99% |
Merck & Co Inc Merck & Co Inc | EC | 50,800 | $6.1M | 1.98% |
Pfizer Inc Pfizer Inc | EC | 216,247 | $6.1M | 1.97% |
Royalty Pharma PLC Royalty Pharma PLC | EC | 126,441 | $6.1M | 1.97% |
Elanco Animal Health Inc Elanco Animal Health Inc | EC | 251,749 | $6.0M | 1.96% |
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC | EC | 31,838 | $6.0M | 1.96% |
Esperion Therapeutics Inc Esperion Therapeutics Inc | EC | 2,194,800 | $6.0M | 1.95% |
Edgewise Therapeutics Inc Edgewise Therapeutics Inc | EC | 190,497 | $6.0M | 1.95% |
MBX Biosciences Inc MBX Biosciences Inc | EC | 200,744 | $6.0M | 1.95% |
Definium Therapeutics Inc Definium Therapeutics Inc | EC | 316,882 | $6.0M | 1.95% |
Bristol-Myers Squibb Co Bristol-Myers Squibb Co | EC | 98,425 | $6.0M | 1.94% |
ANI Pharmaceuticals Inc ANI Pharmaceuticals Inc | EC | 77,382 | $6.0M | 1.93% |
Johnson & Johnson Johnson & Johnson | EC | 24,295 | $5.9M | 1.93% |
Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc | EC | 84,481 | $5.9M | 1.92% |
Trevi Therapeutics Inc Trevi Therapeutics Inc | EC | 494,432 | $5.9M | 1.92% |
Pacira BioSciences Inc Pacira BioSciences Inc | EC | 258,586 | $5.8M | 1.90% |
Zoetis Inc Zoetis Inc | EC | 49,282 | $5.8M | 1.89% |
Crinetics Pharmaceuticals Inc Crinetics Pharmaceuticals Inc | EC | 159,642 | $5.8M | 1.88% |
Nektar Therapeutics Nektar Therapeutics | EC | 80,506 | $5.8M | 1.88% |
Liquidia Corp Liquidia Corp | EC | 153,099 | $5.8M | 1.88% |
Amneal Pharmaceuticals Inc Amneal Pharmaceuticals Inc | EC | 464,477 | $5.8M | 1.88% |
Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Inc | EC | 205,054 | $5.7M | 1.87% |
Supernus Pharmaceuticals Inc Supernus Pharmaceuticals Inc | EC | 110,926 | $5.7M | 1.86% |
Viatris Inc Viatris Inc | EC | 422,585 | $5.7M | 1.85% |
Xeris Biopharma Holdings Inc Xeris Biopharma Holdings Inc | EC | 975,649 | $5.7M | 1.84% |
Harrow Inc Harrow Inc | EC | 159,813 | $5.6M | 1.83% |
Organon & Co Organon & Co | EC | 922,423 | $5.5M | 1.79% |
Nuvation Bio Inc Nuvation Bio Inc | EC | 1,286,168 | $5.5M | 1.79% |
Phibro Animal Health Corp Phibro Animal Health Corp | EC | 99,625 | $5.5M | 1.79% |
Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals Inc | EC | 395,413 | $5.5M | 1.79% |
Indivior Pharmaceuticals Inc Indivior Pharmaceuticals Inc | EC | 179,821 | $5.5M | 1.78% |
Collegium Pharmaceutical Inc Collegium Pharmaceutical Inc | EC | 165,736 | $5.5M | 1.78% |
Eli Lilly & Co Eli Lilly & Co | EC | 5,904 | $5.4M | 1.76% |
Prestige Consumer Healthcare Inc Prestige Consumer Healthcare Inc | EC | 91,089 | $5.4M | 1.75% |
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc | EC | 26,684 | $5.3M | 1.73% |
Ocular Therapeutix Inc Ocular Therapeutix Inc | EC | 621,423 | $5.3M | 1.71% |
Omeros Corp Omeros Corp | EC | 494,846 | $5.2M | 1.70% |
EyePoint Inc EyePoint Inc | EC | 395,677 | $5.1M | 1.66% |
Alumis Inc Alumis Inc | EC | 224,127 | $4.9M | 1.60% |
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc | EC | 227,681 | $4.5M | 1.45% |
Phathom Pharmaceuticals Inc Phathom Pharmaceuticals Inc | EC | 398,901 | $4.4M | 1.44% |
Theravance Biopharma Inc Theravance Biopharma Inc | EC | 268,815 | $4.4M | 1.42% |
Rapport Therapeutics Inc Rapport Therapeutics Inc | EC | 134,504 | $4.2M | 1.37% |
Arvinas Inc Arvinas Inc | EC | 362,073 | $3.8M | 1.25% |
CorMedix Inc CorMedix Inc | EC | 554,307 | $3.8M | 1.22% |
BioAge Labs Inc BioAge Labs Inc | EC | 210,974 | $3.7M | 1.20% |
Maze Therapeutics Inc Maze Therapeutics Inc | EC | 117,041 | $3.5M | 1.13% |
Septerna Inc Septerna Inc | EC | 128,633 | $3.1M | 1.00% |
WaVe Life Sciences Ltd WaVe Life Sciences Ltd | EC | 419,283 | $3.0M | 0.99% |
Zevra Therapeutics Inc Zevra Therapeutics Inc | EC | 324,871 | $3.0M | 0.98% |
Fulcrum Therapeutics Inc Fulcrum Therapeutics Inc | EC | 367,717 | $2.8M | 0.92% |
Aquestive Therapeutics Inc Aquestive Therapeutics Inc | EC | 600,305 | $2.5M | 0.81% |
LB Pharmaceuticals Inc LB Pharmaceuticals Inc | EC | 89,202 | $2.2M | 0.71% |
Alto Neuroscience Inc Alto Neuroscience Inc | EC | 73,288 | $1.6M | 0.54% |
State Street Institutional US Government Money Market Fund State Street Institutional US Government Money Market Fund | STIV | 257,196 | $257,196 | 0.08% |
State Street Institutional US Government Money Market Fund State Street Institutional US Government Money Market Fund | STIV | 5,482 | $5,482 | 0.00% |